Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
LFW Photonics Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Psychedelic/Assisted Therapies
Recent news which mentions Psychedelic/Assisted Therapies
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
New Survey Suggests Psilocybin Eases Psychological Distress From Childhood Trauma
October 19, 2023
Tags
Markets
Psychological Distress
psilocybin therapies
From
Benzinga
EXCLUSIVE: Reason For Hope On Veteran Group Efforts, Comments To FDA & 2023 Expectations
October 18, 2023
Tags
FDA
Psychedelic/Assisted Therapies
Veterans Psychedelics
From
Benzinga
Lucy Scientific's Fiscal Year: Operating Expenses Rise As Accumulated Deficit Hits Over $44M
October 17, 2023
Tickers
LSDI
Tags
Psychedelic/Assisted Therapies
Psychedelics
Benzinga
From
Benzinga
Psyched: FDA Warning, DEA's Telehealth Extension, CA Gov's Veto, Congress On Kratom, M&As & More
October 16, 2023
Tickers
ATAI
CMPS
CYBN
DMTTF
Tags
Penny Stocks
Kratom
SILO
From
Benzinga
U.K.'s Prof. David Nutt Ranked World's Top Psychopharmacologist: More On His Contributions & Advocacy
October 15, 2023
Tickers
AWKNF
Tags
Psychedelic/Assisted Therapies
ScholarGPS
Drug Science
From
Benzinga
Dem Presidential Candidate Calls For Universal Healthcare, Including Psychedelics Therapy
October 13, 2023
Tags
General
Presidential race
Psychedelic/Assisted Therapies
From
Benzinga
Cybin And Small Pharma Shareholders Green Light Acquisition Resolution: Results & Expected Dates
October 13, 2023
Tickers
CYBN
DMTTF
Tags
Benzinga
Psychedelics
CYBN
From
Benzinga
Pioneering Hope: Inside The Veteran's Organization Advancing Psychedelics Reform Policy
October 12, 2023
Tags
Cannabis
Market News
Markets
From
Benzinga
EXCLUSIVE: Understanding Real Estate For Psychedelic Treatments Boosted By Geospatial Mapping
October 07, 2023
Tickers
AAPL
IBM
Tags
Tyler Zakovich
Psychedelics
Real Estate
From
Benzinga
EXCLUSIVE: The Need To Enhance Psychedelic Therapy Infrastructure, Data-Driven Solutions
October 06, 2023
Tags
Market News
Cannabis
Markets
From
Benzinga
Maine's Portland Leads Drug Policy Reform, Decriminalizing Psychedelic Plants And Fungi
October 04, 2023
Tags
Maine
News
Markets
From
Benzinga
Decoding Insurance Reimbursement For Psychedelic-Assisted Therapy With BrainFutures Guide
October 04, 2023
Tags
News
Psychedelics
Benzinga
From
Benzinga
Atai Life Sciences Completes Phase 1 Clinical Study Of Oral Film DMT Formulation
October 03, 2023
Tickers
ATAI
Tags
Management
Psychedelic/Assisted Therapies
Benzinga
From
Benzinga
Cybin Completes Dosing In Phase 2 Study Of CYB003 For Major Depressive Disorder Treatment
October 03, 2023
Tickers
CYBN
Tags
Deuterated Psychedelics
Benzinga
Psychedelics
From
Benzinga
Steve Cohen Keeps Betting On Biopharma With Purchase Of 119M+ Bionomics Shares
October 03, 2023
Tickers
BNOX
CYBN
MRK
Tags
CYBN
Financing
Point72 Asset Management
From
Benzinga
Insider's Look At Psychedelics Industry On Risk Management, Gray Market & Cannabis Industry
October 03, 2023
Tags
Interview
Psychedelics
Benzinga
From
Benzinga
GH Research's Psychedelic Drug Candidate For Depression Meets FDA: Clinical Program On Hold
October 02, 2023
Tickers
GHRS
Tags
Investigational New Drug Application
Market News
Cannabis
From
Benzinga
Gov Newsom Green Lights Medical Psychedelics If Rescheduled And New Marijuana Testing Rules
October 02, 2023
Tags
Cannabis
Gov/ Gavin Newsom
Market News
From
Benzinga
Psychedelic Therapy Providers: Risk Management Perspective From A Cannabis Insurance Specialist
October 02, 2023
Tags
Cannabis
Market News
Markets
From
Benzinga
Argentina's Nacho Bottinelli On Psychedelics In Latin America: 'Brazil Opened A Giant Portal To Me'
October 02, 2023
Tags
Exclusives
News
Brazil Psychedelics
From
Benzinga
Psyched: DMT & SSRIs For Depression, MDMA Training, Negative Responses To Psychedelics & More
October 02, 2023
Tickers
ATAI
CMPS
CYBN
DMTTF
Tags
Psychedelic/Assisted Therapies
CMPS
IXHL
From
Benzinga
Psychedelics Reform Update: Massachusetts, Pennsylvania, Maine, California, Michigan, Minnesota, Indiana
September 30, 2023
Tags
Psychedelics Reform
Management
Legal
From
Benzinga
PharmaTher Is 'One Step Closer To Being A Ketamine Leader' Due To FDA Acceptance
September 27, 2023
Tickers
PHRRF
Tags
Guidance
News
Health Care
From
Benzinga
Cybin And Fluence Partner To Support EMBARK Training For Phase 3 CYB003 Trial For Depression
September 26, 2023
Tickers
CYBN
Tags
Guidance
News
Penny Stocks
From
Benzinga
Depression Relief: Possible Therapy Boost With DMT & SSRIs, Per Small Pharma Clinical Results
September 26, 2023
Tickers
CYBN
DMTTF
Tags
Penny Stocks
News
DMTTF
From
Benzinga
Defense Dept. Grants $1M To Yale & Transcend Therapeutics To Study PTSD Therapy
September 26, 2023
Tags
Markets
Market News
Cannabis
From
Benzinga
Psyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And More
September 26, 2023
Tickers
ATAI
CMPS
CYBN
DMTTF
Tags
LSDI
Cannabis
ATAI
From
Benzinga
Microdosing Unveiled: Expert's Take On The Practice's Ups & Downs
September 24, 2023
Tickers
META
Tags
LSD Microdosing
Psychedelic/Assisted Therapies
Paul Austin
From
Benzinga
Cybin Delivers Highest Dose Of Psilocybin Analog In Phase 2 For Major Depression
September 21, 2023
Tickers
CYBN
DMTTF
Tags
CYBN
Psychedelic/Assisted Therapies
FDA
From
Benzinga
Enveric Biosciences Nabs U.S. Patent For Novel Psilocybin Derivatives, Details Here
September 21, 2023
Tickers
ENVB
Tags
Psychedelic/Assisted Therapies
Psychedelics
Benzinga
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.